CXCL10 and neoplasm: Type I IFNs aid in chemotherapy-induced ICD mainly through autocrine or paracrine signaling cascade, elicit immunostimulatory effect via IFNAR signaling in immune cells, and trigger CXCL10 secretion by tumor cells (40, 42).